摘要
目的评估中文版多维健康评估量表(MDHAQ-C)在中国RA病情评估中的临床价值。方法2015年12月至2016年10月现场调查RA患者共412例,独立完成MDHAQ-C,计算患者数据指标常规评估值3(RAPID3),通过Spearman相关分析比较RAPID3和疾病临床指标及疾病活动指数DAS28-ESR、临床疾病活动指数(CDAI)、简化的疾病活动指数(SDAI)的相关性。结果RAPID3和ESR(r=0.399)、CRP(r=0.381)、肿胀关节数(SJC)(r=0.499)、压痛关节数(TJC)(r=0.558)中度相关(P〈0.01);和疼痛视觉模拟评分法(VAS)(r=0.836)、患者病情自我评估VAS评分(r=0.915)及医生病情VAS评分(r=0.780)强相关(P〈0.001);和疾病活动指数DAS28-ESR(r=0.784)、CDAI(r=0.734)、SDAI(r=0.682)强相关(P〈0.01)。结论MDHAQ-C用于RA疾病活动评估临床价值高,且操作简便,适用于临床工作。
Objective To evaluate the clinical value of Chinese Multi-Dimensional Health Assessment Questionnaire (MDHAQ-C) in patients with rheumatoid arthritis (RA).MethodsFrom December 2015 to October 2016, four hundred and twelve RA patients were recruited in this study and completed the MDHAQ-C independently and routine assessment of patient index data 3 (RAPID3) was calculated. Then correlations were assessed by Spearman correlation coefficient of RAPID3 with indices of clinical relevance and disease activity to evaluate its clinical values.ResultsMDHAQ-C is moderately correlated with ESR (r=0.399), CRP (r=0.381), SJC (r=0.499), TJC (r=0.558) (P〈0.01), but highly correlation with VAS of pain (r=0.836), VAS of global status (r=0.915) and overall assessment of physician (r=0.784)(P〈0.01), and highly correlated with a Spearman's coefficient of 0.784 for DAS 28-ESR, 0.734 for CDAI and 0.682 for SDAI(P〈0.001).ConclusionMDHAQ is a reliable, valid instrument for disease activity assessment and a feasible index for clinical settings in Chinese RA patients.
出处
《中华风湿病学杂志》
CSCD
北大核心
2017年第10期652-656,共5页
Chinese Journal of Rheumatology
基金
国家自然科学基金(81373117,81429003,31530020)
关键词
关节炎
类风湿
中文版多维健康评估量表
临床价值
Arthritis, rheumatoid
Chinese multi-dimensional health assessment questionnaire
Clinical value